BioAge Labs (BIOA) Total Liabilities (2023 - 2026)

BioAge Labs has disclosed Total Liabilities across 4 years of filings, most recently posting $22.0 million for Q2 2026.

• In Q2 2026, Total Liabilities fell 19.55% year-over-year to $22.0 million; the TTM figure through Jun 2026 stood at $22.0 million (down 19.55% YoY), while the FY2025 annual figure was $22.8 million, down 34.95% from the prior year.
• Total Liabilities came in at $22.0 million for Q2 2026 at BioAge Labs, up from $18.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $197.1 million in Q2 2024 to a low of $18.5 million in Q1 2026.
• Average Total Liabilities over 4 years is $67.5 million, with a median of $29.2 million recorded in 2025.
• The largest YoY upside for Total Liabilities was 16.9% in 2025 against a maximum downside of 86.12% in 2025.
• Over 4 years, Total Liabilities stood at $66.6 million in 2023, then slumped by 47.29% to $35.1 million in 2024, then slumped by 34.95% to $22.8 million in 2025, then decreased by 3.6% to $22.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $22.0 million in Q2 2026, $18.5 million in Q1 2026, and $22.8 million in Q4 2025.